Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
15.16
-0.51 (-3.25%)
At close: Oct 30, 2026, 4:00 PM EDT
15.30
+0.14 (0.92%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.06 billion as of October 30, 2026. Its market cap has decreased by 3.58% in one year.
Market Cap
2.06B
Enterprise Value
2.09B
1-Year Change
-3.58%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.06B, an increase of 248.06%. That is a compound annual growth rate of 12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 2.03B | -11.99% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 2.20B |
| Vera Therapeutics | 2.20B |
| Vericel | 2.20B |
| Maravai LifeSciences Holdings | 2.20B |
| Palvella Therapeutics | 2.18B |
| Xencor | 2.17B |
| Septerna | 2.11B |
| Immunome | 2.08B |